entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 05:00:04 - browse：3916

To scientists' surprise in a new study, a common genetic deletion in schizophrenia cases was linked to problems in mitochondria. Adobe

The heritable nature of schizophrenia has been known for about a century. But researchers are still trying to learn how genes that have been linked to an increased risk of the disease actually lead to schizophrenia.

For decades, those genetic underpinnings of schizophrenia have fascinated Jennifer Mulle, an associate professor at the Rutgers Center for Advanced Biotechnology and Medicine. When she was a master’s student in public health, she set out to locate a place in the DNA that held the secrets of the condition. “We did really beautifully, carefully designed studies,” she said. “And there was nothing.”

In the early 2000s, before they knew many genes factor into schizophrenia, researchers were looking for a single gene that would be culpable for the devastating illness. Mulle spent nearly a decade on the hunt, through her Ph.D. program and into her postdoctoral fellowship at Emory University. Under the mentorship of Stephen Warren, who founded the medical school’s department of human genetics and unearthed the genetics of fragile X syndrome, she finally found something.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： All of Us, NIH's precision medicine initiative, gets a big boost

WSS

Pharma patents targeted by Biden in move to slash drug prices

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Key Senate panel to consider PBM, drug pricing reform package

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

After Sarepta trial failure, Duchenne families brace for more debate

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

hotspot

entertainment

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CMS should re

Trump demands the U.S. pay no more for drugs than other countries … again

What causes an itch? Researchers may have solved the mystery

Apple is now the first public company to be valued at $3 trillion

Teach medical students about patients with intellectual disabilities

Anesthesiologist group: stop taking Ozempic before surgery

Pregnancy discrimination could be enabled by AI

focus

The health care issue Democrats can’t solve: hospital reform

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Pfizer plans to depart BIO

Chemotherapy shortages won’t get better under Biden’s latest plan

Roche to buy Carmot Therapeutics, developer of obesity drugs

Roche to buy Carmot Therapeutics, developer of obesity drugs

focus

entertainment

explore

focus